Insulin resistance, which is commonly associated with obesity, has been shown to promote prostate cancer by increasing circulating levels of bioactive IGF-1, a growth factor implicated in numerous types of cancer [74,75]. Here, IGF1 is linked to obesity due to melanocortin 4 receptor deficiency.